期刊文献+

具核梭杆菌与结直肠癌关系的研究进展

Advance in research on the relation between Fusobacterium nucleatum and colorectal cancer
原文传递
导出
摘要 结直肠癌(Colorectal cancer,CRC)是世界第三大癌症,涉及因素众多,而肠道菌群失调、菌群致病性与结直肠癌的发生、发展有着密不可分的关系。近期的研究发现具核梭杆菌(Fusobacterium nucleatum,F.nucleatum)与结直肠癌的发生存在显著的相关性。具核梭杆菌为革兰阴性厌氧菌,广泛存在于人体肠道中。分子机制研究发现,其能影响宿主细胞因子水平,促进血管生成、巨噬细胞M2极化和抑制机体免疫调节能力,进而增强肿瘤细胞增殖、侵袭及转移。本文就具核梭杆菌与结直肠癌相关机制研究进展作一综述。 Colorectal cancer(CRC) is the third largest cancer in the world, involving many factors. Intestinal dysbacteriosis and flora pathogenicity are closely related to the occurrence and development of CRC. Recent studies have found a significant correlation between Fusobacterium nucleatum(F.nucleatum) and the presence of CRC. F.nucleatum is a Gram-negative anaerobic bacterium widely exists in human intestine. Molecular mechanism studies have found that it can affect the level of host cytokines, promote angiogenesis and macrophage M2 polarization, inhibit the body′s immune regulation and enhance tumor cell proliferation, invasion and metastasis. This article reviews the progress in research on the mechanism of F.nucleatum and CRC.
作者 黎清 蔡江滢 傅思武 陈琴艳 刘小青 蔡贺南 王承建 LI Qing;CAI Jiang-ying;FU Si-wu;CHEN Qin-yan;LIU Xiao-qing;CAI He-nan;WANG Cheng-jian(Medical school of Northwest Minzu University,Lanzhou,Gansu 730030,China;不详)
出处 《中国微生态学杂志》 CAS CSCD 2021年第2期246-248,F0003,共4页 Chinese Journal of Microecology
基金 中央高校基本科研业务费项目(31920170163) 西北民族大学国家大学生创新创业训练计划项目(202010742118)。
关键词 结直肠癌 具核梭杆菌 CRC F.nucleatum
  • 相关文献

参考文献1

二级参考文献96

  • 1Schwabe RF, Jobin C. The microbiome and cancer. Nat RevCancer 2013; 13: 800-812 [PMID: 24132111 DOI: 10.1038/nrc3610].
  • 2Dickson RP, Martinez FJ, Huffnagle GB. The role of themicrobiome in exacerbations of chronic lung diseases.Lancet 2014; 384: 691-702 [PMID: 25152271 DOI: 10.1016/S0140-6736(14)61136-3].
  • 3Kahn SE, Cooper ME, Del Prato S. Pathophysiology andtreatment of type 2 diabetes: perspectives on the past, present,and future. Lancet 2014; 383: 1068-1083 [PMID: 24315620 DOI:10.1016/S0140-6736(13)62154-6].
  • 4Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology--analysis of host and tumor factors for personalized medicine. NatRev Clin Oncol 2011; 8: 711-719 [PMID: 21826083 DOI: 10.1038/nrclinonc.2011.122].
  • 5Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassengermodel for colorectal cancer: beyond the usual suspects.Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI:10.1038/nrmicro2819].
  • 6Signat B, Roques C, Poulet P, Duffaut D. Fusobacteriumnucleatum in periodontal health and disease. Curr Issues Mol Biol2011; 13: 25-36 [PMID: 21220789].
  • 7Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, GroteVA, Tjneland A, Dahm CC, Overvad K, Jenab M, Fedirko V,Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R,Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D,Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD,Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E,Dorronsoro M, Quir JR, Duell EJ, Ye W, Sund M, Lindkvist B,Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Buenode-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria andrisk of pancreatic cancer in a large European prospective cohortstudy. Gut 2013; 62: 1764-1770 [PMID: 22990306 DOI: 10.1136/gutjnl-2012-303006].
  • 8Michaud DS. Role of bacterial infections in pancreatic cancer.Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI:10.1093/carcin/bgt249].
  • 9Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N.Induction of experimental ulcerative colitis by Fusobacteriumvarium isolated from colonic mucosa of patients with ulcerativecolitis. Gut 2003; 52: 79-83 [PMID: 12477765].
  • 10Minami M, Ando T, Okamoto A, Sasaki N, Ohkura T, Torii K,Hasegawa T, Ohta M, Goto H. Seroprevalence of Fusobacteriumvarium in ulcerative colitis patients in Japan. FEMS Immunol MedMicrobiol 2009; 56: 67-72 [PMID: 19484811].

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部